Novel postremission strategies in adults with acute myeloid leukemiaLANCET, Jeffrey E; KARP, Judith E.Current opinion in hematology. 2009, Vol 16, Num 2, pp 105-111, issn 1065-6251, 7 p.Article

Farnesyl transferase inhibitors in myeloid malignanciesLANCET, Jeffrey E; KARP, Judith E.Blood reviews. 2003, Vol 17, Num 3, pp 123-129, issn 0268-960X, 7 p.Article

Farnesyl protein transferase inhibitors as targeted therapies for hematologic malignanciesKARP, Judith E.Seminars in hematology. 2001, Vol 38, Num 3, pp 16-23, issn 0037-1963, SUP7Conference Paper

Farnesyltransferase inhibitors in hematologic malignancies: new horizons in therapyLANCET, Jeffrey E; KARP, Judith E.Blood. 2003, Vol 102, Num 12, pp 3880-3889, issn 0006-4971, 10 p.Article

Overcoming drug resistance: targeting more than one siteKARP, Judith E; MOOKERJEE, Bijoyesh P.Leukemia research. 2002, Vol 26, Num 1, pp 107-109, issn 0145-2126Article

Effective Chemotherapy of Acute Myelocytic Leukemia Occurring After Alkylating Agent or Radiation Therapy for Prior MalignancyVAUGHAN, William P; KARP, Judith E; BURKE, Philip J et al.VAUGHAN, William P; KARP, Judith E; Journal of clinical oncology. 2008, Vol 26, Num 21, issn 0732-183X, C165-C168, 3475-3477Article

The impact of biology on the treatment of secondary AMLGOJO, Ivana; KARP, Judith E.Cancer treatment and research. 2001, Vol 108, pp 231-255, issn 0927-3042Article

Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity : Role in Kaposi's sarcoma inflammation?SAMANIEGO, Felipe; PATI, Shibani; KARP, Judith E et al.Journal of the National Cancer Institute. Monographs. 2000, Num 28, pp 15-23, issn 1052-6773Conference Paper

Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemiaKARP, Judith E; GARRETT-MAYER, Elizabeth; LEVIS, Mark J et al.Haematologica (Roma). 2012, Vol 97, Num 11, pp 1736-1742, issn 0390-6078, 7 p.Article

A rapid and sensitive method for determination of veliparib (ABT-888), in human plasma, bone marrow cells and supernatant by using LC/MS/MSREINHARDT, Sarah; MING ZHAO; MNATSAKANYAN, Aleksander et al.Journal of pharmaceutical and biomedical analysis. 2010, Vol 52, Num 1, pp 122-128, issn 0731-7085, 7 p.Article

Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasmsGORE, Steven D; BAYLIN, Stephen; RUDEK, Michelle A et al.Cancer research (Baltimore). 2006, Vol 66, Num 12, pp 6361-6369, issn 0008-5472, 9 p.Article

Plasma inhibitory activity (PIA) : a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitorsLEVIS, Mark; BROWN, Patrick; KANTARJIAN, Hagop et al.Blood. 2006, Vol 108, Num 10, pp 3477-3483, issn 0006-4971, 7 p.Article

Phase I and pharmacologic study of infusional topotecan and carboplatin in relapsed and refractory acute leukemiaKAUFMANN, Scott H; KARP, Judith E; LITZOW, Mark R et al.Clinical cancer research. 2005, Vol 11, Num 18, pp 6641-6649, issn 1078-0432, 9 p.Article

Phase I and pharmacokinetic study of flavopiridol followed by 1-β-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemiasKARP, Judith E; PASSANITI, Antonino; TIDWELL, Michael L et al.Clinical cancer research. 2005, Vol 11, Num 23, pp 8403-8412, issn 1078-0432, 10 p.Article

Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposideBOLANOS-MEADE, Javier; KARP, Judith E; GUO, Chuanfa et al.Leukemia research. 2003, Vol 27, Num 4, pp 313-321, issn 0145-2126, 9 p.Article

Metabolic and electrochemical mechanisms of dimeric naphthoquinones cytotoxicity in breast cancer cellsEMADI, Ashkan; LE, Anne; HARWOOD, Cynthia J et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 23, pp 7057-7062, issn 0968-0896, 6 p.Article

Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemiaKAUFMANN, Scott H; KARP, Judith E; MAURER, Matthew J et al.Haematologica (Roma). 2011, Vol 96, Num 11, pp 1619-1626, issn 0390-6078, 8 p.Article

Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitroWAHNER HENDRICKSON, Andrea E; HALUSKA, Paul; CARBONI, Joan M et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 19, pp 7635-7643, issn 0008-5472, 9 p.Article

A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemiasKARP, Judith E; RICKLIS, Rebecca M; GANDHI, Varsha et al.Blood. 2007, Vol 110, Num 6, pp 1762-1769, issn 0006-4971, 8 p.Article

Targeting Vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: Therapy with sequential 1-β-D-arabinofuranosylcytosine, mitoxantrone, and bevacizumabKARP, Judith E; GOJO, Ivana; ZWIEBEL, James et al.Clinical cancer research. 2004, Vol 10, Num 11, pp 3577-3585, issn 1078-0432, 9 p.Article

Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemiaKARP, Judith E; VENER, Tatiana I; CARRAWAY, Hetty E et al.Blood. 2012, Vol 119, Num 1, pp 55-63, issn 0006-4971, 9 p.Article

New Lesions Detected by Single Nucleotide Polymorphism Array-Based Chromosomal Analysis Have Important Clinical Impact in Acute Myeloid LeukemiaTIU, Ramon V; GONDEK, Lukasz P; ADVANI, Anjali S et al.Journal of clinical oncology. 2009, Vol 27, Num 31, pp 5219-5226, issn 0732-183X, 8 p.Conference Paper

Sequential flavopiridol, cytosine arabinoside, and mitoxantrone : A phase II trial in adults with poor-risk acute myelogenous leukemiaKARP, Judith E; SMITH, B. Douglas; LEVIS, Mark J et al.Clinical cancer research. 2007, Vol 13, Num 15, pp 4467-4473, issn 1078-0432, 7 p., 1Article

Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabineMESA, Ruben A; LOEGERING, David; TEN EYCK, Cynthia J et al.Blood. 2005, Vol 106, Num 1, pp 318-327, issn 0006-4971, 10 p.Article

Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cellsCHANDRA, Joya; HACKBARTH, Jennifer; KARP, Judith E et al.Blood. 2003, Vol 102, Num 13, pp 4512-4519, issn 0006-4971, 8 p.Article